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ABSTRACT 
 
Autoimmune diseases arise due to tolerance breakdown or failure of the body's immune 
system to establish tolerance leading to the body failing to recognize its own tissues and 
organs as self. Systemic sclerosis is a disease of the connective tissue characterized by 
immunological abnormalities and increased deposition of extracellular matrix proteins in the 
skin. Vitiligo is a dermatological disorder characterized by loss of melanocytes from the 
cutaneous epidermis. The aim of this project was to confirm the previously identified QTLs in 
the Smyth line (SL) chicken model of vitiligo in F3-F5 generations of the SL and Brown line 
(BL) cross and systemic sclerosis in the University of California at Davies (UCD 200) model 
in the 2nd backcross generations (BC2) of UCD 200 and red jungle fowl cross (RJF). We 
confirm the association of the disease with our marker genotypes on chromosome 3 but not on 
chromosomes 9 and 21 in the SL and BL crosses from F3-F5 generations. We did not confirm 
the disease association with chromosomes 2, 12, 14 and 19 in the BC2 generation from the 
UCD x RJF cross because the pedigree was not large enough for the analysis. 68% of the 
individuals in the BC2 pedigree expressed the diseases with males showing 100% liability. 
We recorded a mortality rate of approximately 50% in the BC2 population.  We did not 
observe any significant mortality in the intercrosses between the SL and BL. 
 
Keywords: chicken, autoimmune disease, animal models, systemic sclerosis, vitiligo 
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BACKGROUND 
 
Chickens and humans shared a common ancestor approximately 310 million years ago 
(Hedges 2002, Hillier et al. 2004 and Burt 2005). The red jungle fowl (Gallus gallus) is 
considered to be the ancestor of all domestic chickens (West and Zou 1988, Fumihito et al. 
1994, Wong 2001, Kanginakudru 2008). The chicken (Gallus gallus domesticus) was 
domesticated over 8 000 years ago in South East Asia. It was originally used for religious 
purposes, leisure, cock fighting and the Romans used the chicken as oracles (Crawford 1996). 
It was later used as an agricultural animal with specialized breeds generated for different 
purposes. It is a source of protein (meat and eggs) with billions of eggs used each year (Burt 
2005). Some chickens are kept as pets such as the Bantam and the Silkies since they are more 
docile (Clucks & Chooks 2008). 
 
The chicken as an animal model  
 
Animal models are important in providing clues for understanding human diseases. Evidence 
of the use of chicken as an animal model described by Aristotle was the use of chicken in 
embryology. Harvey (1628) studied blood circulation using chickens while Pasteur (1880) 
discovered transmission of infections in chickens through attenuating a virulent pathogen of 
chicken cholera. Today, the chicken is an important experimental system for developmental 
biology, immunology, microbiology, genetics, virology and cancer (Jimenez et al. 1984, 
Brown et al. 2003, International Chicken Genome Sequencing Consortium 2004 and Stern 
2005). Animal models for understanding diseases were based on whether the diseases are 
induced by exogenous compounds or genetically inherited as a trait (Van de Water et al. 
1995). 
Experimental animal models that spontaneously develop autoimmune diseases reflect 
the human situation more closely compared with models where the disease has been induced 
(Erf 2010). Even though murine models have been broadly used in biomedical research for 
autoimmune diseases they are very rare and currently there is no model that spontaneously 
develops autoimmune vitiligo (Erf 2010). 
The chicken has several advantages as an animal model for studies of biological 
processes and they include a rich genetic diversity, large population size, ease of breeding, 
high rates of recombination (Kerje 2003, Siegel et al. 2006) and this has been enhanced by 
the construction of the chicken genome sequence and identification of 2.8 million SNPs 
(International Chicken Genome Sequencing Consortium 2004 and International Chicken 
Polymorphism Map Consortium 2004).  
 
Chicken models of autoimmune diseases  
 
Chicken model of systemic sclerosis 
Complex pathophysiology of scleroderma/systemic sclerosis (SSc) has led to the development 
of animal models, which gives a closer look at pathophysiology of the disease such as 
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functions of various cell types like monocytes, T-lymphocytes, fibroblasts and mast cells 
(Haustein 2002). 
The University of California at Davies lines 200 and 206 (UCD 200 and 206) 
developed by Bernier in 1942 have become ideal models for the study of SSc since they show 
the entire manifestation of clinical, histopathological and serological spectrum of SSc while 
other animal models (tight skin mice) of SSc lack vascular damage (Sgonc 1999 and Wick et 
al. 2006). In this chicken model, F1 generation show no incidence of the disease while F2 
generation had a disease incidence of 4%.  
 
Other animal models of SSc  
Other animal models of SSc include the tight skin mouse (Tsk). The tsk mouse has thickened 
skin that is tightly bound to the subcutis and deep muscular tissue. Compared to human 
scleroderma, the tsk mice lack dermal sclerosis and fibrosis is deeper than in humans but 
biochemical and molecular abnormalities similar to human SSc were noted (Yamamoto 
2010). 
In bleomycin-induced scleroderma, bleomycin (an isolate from fungus Streptomyces 
verticulus) is used. Bleomyin is usually used as an anti-tumour antibiotic and has several 
biochemical properties which include blocking the cell cycle at G2, produces free radicals that 
induces apoptosis and exerts effects on skin-constituted cells such as fibroblasts, 
keratinocytes, endothelial cells and immunocytes. It also up-regulates collagen and TGF-β 
mRNA expression (in lungs of rats and skin fibroblasts of humans) and augments gene 
expression of extra cellular mass proteins (ECM) together with fibrotic cytokines (Yamamoto 
2000; 2009; 2010). 
 
 
Fig. 1. Possible pathogenesis of bleomycin induced systemic sclerosis. MMP is matrix 
metalloproteinase NO is nitric oxide. Yamamoto 2010. 
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In the fibrosis mouse model of TGF-β/CTGF, mice injected with TGF-β showed 
granulation and fibrosis of the skin (Yamamoto 2005). TGF is a powerful stimulus for in vitro 
formation of collagen and induces fibrosis and angiogenesis in newborn mice. It is suggested 
that TGF-β is has an important role in inducing granulation and fibrotic tissue formation 
whereas CTGF maintains fibrosis (Kanzler et al. 1999; Takehara 2003) 
 
Chicken model of vitiligo 
The Smyth line (SL), developed by Dr J Robert Smyth in the 1970s is well established as an 
animal model of vitiligo (Smyth 1980). SL chickens show post hatch loss of melanin 
synthesizing melanocytes in feather and choroid tissue. The SL chicken is the only animal 
model that mimics the entire spectrum of clinical and biological manifestations of the 
corresponding human disease (Wick et al. 2006). 
Liability of vitiligo in the Smyth line is 70-95% within the contemporary group and 
de-pigmentation in the feathers is seen at 6-20 weeks of age with animal showing complete 
de-pigmentation in adulthood (Erf 2007). However, the parental Brown line (BL101) with 
matched major histocompatibility complex (MHC) has less than 2% incidence of vitiligo 
while the Light Brown (LBL101) is resistant against development of vitiligo. 
Incidences of the disease in this animal model are predictable and the lesions are 
easily accessible since the feather tissue regenerates. Smyth (1989) characterized the disorder 
as spontaneous vitiligo-like loss of melanin producing cells in the feathers and the choroid 
after hatching.  
 
Other animal models of vitiligo 
Several species having naturally occurring de-pigmentation have been proposed as models for 
vitiligo. One example is Grey horses such as Lipizzaner, Arabian and Andalusian. These 
horses are normally coloured at birth and those carrying the dominant Grey allele show de-
pigmentation after birth which increases with age until they appear completely white at 
maturity (Boissy and Lamoreux 1988), nevertheless a duplication of the STX17-region was 
denoted to be the causative mutation leading to premature loss of pigment and melanoma in 
these horses (Pielberg et al. 2008), and therefore this is not a good model for autoimmune 
disease as no autoimmune component is involved. 
The Sinclair miniature swine model of vitiligo develops spontaneous regression of 
cutaneous malignant melanoma lesions (Hook et al. 1982). This pig is considered a good 
model for spontaneous melanoma. De-pigmentation is associated with the tumours together 
with development of uveitis and vitiligo and there is evidence of immune system involvement 
in tumour regression and development of vitiligo (Erf 2010). Vitiligo in the water buffalo was 
observed to resemble vitiligo in humans in cytological aberrations of melanocytes but no 
autoimmune component has been confirmed (Cerundolo et al. 2007).  
The vitiligo mouse (C57B1/J6vit/vit) has in addition to progressive loss of hair and 
ocular pigmentation with age also contact allergens as observed in human vitiligo (Boissy et 
al. 1987). However, the phenotype was mapped to the microphthalmia (MITF) locus (mivit/vit) 
(Lamoureux et al. 1992) and therefore this animal model was excluded as a model for 
autoimmune vitiligo.  
The Barred Plymouth Rock and White Leghorn chicken lines were thought to be 
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models of vitiligo (Bowers et al. 1992). In Barred Plymouth Rock chickens, the black and 
white band patterns results from autophagocytic degeneration of melanocytes, which are not 
present in the white bands. The barring phenotype was lately linked to two non-coding 
mutations in the CDKN2A and two missense mutations in a highly conserved region 
(Hellström et al. 2010). The barring gene was found to inhibit melanin deposition in the 
feathers, beak, shanks and the eyes of the chicken (Erf 2010). The white feathers in the White 
Leghorns are known to be caused by a mutation in the PMEL17 gene (Kerje et al. 2004). Due 
to the fact that all de-pigmentation phenotypes described above are caused by mutations in 
single genes eliminates all of them as models for autoimmune vitiligo. 
 
AUTOIMMUNE DISEASES  
 
Autoimmune diseases arise as a result of failure of the body to recognize its own cells and 
tissues allowing the immune system to respond against something which is usually not a 
threat or non-foreign. This normally happens when immune tolerance is broken or not well 
established. Immunological tolerance is the failure to mount an immune response to an 
antigen which helps the body not to attack its own tissues and other antigens 
(http://www.herb.co.za/herb-remedies/immune-system01.htm).  
Central tolerance is a key feature in autoimmune diseases. It is a mechanism by which 
developing T-cells and B-cells are rendered non-reactive to healthy tissues and it is induced at 
the primary site of the lymphocytes (Hogquist et al. 2005). Self antigens are transported to the 
thymus where clonal deletion or tolerance of self-reactive thymocytes is induced (Sprent 
1995). Autoimmune disorders fall into two categories: systemic, which damages many organs 
and localized which attacks specific organs and tissues even though it can extend beyond the 
targeted tissue to other body organs (Ravel and Descotes 2004 and http://www.aacc.org). The 
precise cause of autoimmune diseases is generally unknown but it is suggested that there 
appears to be some genetic predisposition to develop autoimmune disease in many cases and 
environmental factors have a role in triggering the disorders.  
 
Systemic sclerosis 
Systemic sclerosis is a heterogeneous disorder that affects the connective tissue of the skin 
and internal organs such as the lungs, intestinal track, heart and kidney (Haustein 2002). It is 
characterized by vasomotor disturbances, fibrosis, subcutaneous and skin atrophy as well as 
muscle and arterial occlusion of internal organs, polyarthritis and presence of antinuclear 
antibodies, peri-vascular mononuclear cell-infiltration and increased deposition of extra 
cellular matrix, microvascular damage, immune system disturbance and massive collagen 
deposition (Gershwin et al. 1981, Sgonc 1999, Yamamoto 2002, Jimenez and Derk 2004, 
Schwartz et al. 2009, Rabquer et al. 2009).   
Aetiology of SSc is assumed to be immunologic mechanisms, genetic risk factors and 
environmental triggers as well as interaction between genetic risk factors and environmental 
triggers (Jin et al. 2007, Rula and Hajj-Ali 2008, Maron et al. 2010). In humans, familial 
clustering of SSc is rare (Van de Water and Gershwin 1985) and this might be because 
familial cases of the disease have not been well documented or environmental factors are very 
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important and this can be proven in the UCD 200 and 206 lines since they have been heavily 
selected for the disease.  
In humans, SSc is characterized by fatigue, intolerance to cold, pain, deformity and 
loss of function of the hand as well as change in facial appearance (Medsger 1991). 
Pathohistological findings indicated that fibroblasts, endothelial cells and lymphocytes are 
key main players in three major clinical observations which are fibrosis of cutaneous and 
viscera, vascular alterations and immunological alterations (Wick et al 2006, Yamamoto 
2005, 2009). Progressive thickening and fibrosis of the skin is usually noted and in subclinical 
cases internal organs are affected (Fleischmajer et al. 1977, Haustein 2002 and Wick et al. 
2006). In humans, SSc starts with oedema of the fingers preceded by Raynaud's phenomenon 
(Yamamoto 2009). Raynaud's phenomenon is discolouration of the fingers or toes due to 
reduced blood flow caused by vasoconstriction. Fibrosis can be caused by profibrotic 
cytokines including TGF-beta, interleukin 4 (IL-4), and platelet derived growth factor 
(PDGF) (http://www.aacc.org).  
In the UCD 200 chickens, SSc is characterized by swelling, erytheroma and necrosis 
of the comb (self dubbing) (Fig. 1) (Van de Water and Gershwin 1985). Van de Water and 
Gershwin (1985) also observed swelling of the peripheral joints as well as polyarthritis, 
swelling of the upper neck sac after four weeks of age. Other visceral organs involved include 
oesophagus (64%), small intestine (60%), lung (60%), kidney (65%), heart (30%) and testis 
(66%).  
Antinuclear-antibodies have been detected in 65% of the UCD 200 chickens at six 
months of age, and it was noted that such chickens also produced rheumatoid factor at four 
months of age (Van de Water and Gershwin 1985). 
A comparative study of skin biopsies from UCD 200 chickens and biopsies from 
human SSc patients revealed that endothelial cell apoptosis induced by anti-endothelial cell 
antibody (AECA) - dependent cellular cytotoxicity is a principal event in the pathogenesis of 
SSc (Sgonc 1999). Histopathological findings of the skin involve inflammatory infiltrates of 
lymphocytes, monocytes, plasma, histiocytes around the blood vessels and sweat glands. 
Infiltrating immunocytes releases fibrogenic cytokines, which play a very crucial role in the 
initiating events in SSc (Jimmenez et al. 1986). Comparative details of SSc in both humans 
and chickens are described in Table 1. 
 
  
Fig. 2. UCD 200 chickens showing swelling and necrosis of the comb (Photos. S Kerje) 
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Fig. 3. Systemic sclerosis patients showing polyarthritis in fingers equivalent to feet necrosis in 
chickens. 
 
Treatment 
Several vitamins, pharmaceuticals, hormones, drugs and surgical procedures are reported to 
be successful in the treatment of systemic sclerosis and these treatments have been well 
accepted by the public (Medsger 1991). 
 
Table 1. Comparison of clinical, biochemical, immunological, and pathologic features of human and 
avian SSc, source Wick et al. 2006. 
 Human SSc Avian SSc 
Clinical features 
Disease presentation Subtle, middle age Acute, early in life 
Skin fibrosis Present Present 
Esophageal fibrosis Present Present 
Lung fibrosis Present Present 
Kidney involvement Present Present 
Heart involvement Present Present 
Polyarthritis Present Present 
Eye involvement Debated Absent 
Autoimmune features 
Autoantibodies 
ANA Present Present 
Anti-Scl-70 Present Absent 
Anticentromere Present Present 
Anticytoplasmic Present Present 
Autoreactive T cells Present Present 
Aetiology 
Genetic susceptibility Necessary not sufficient Necessary and sufficient 
http://www.goldbamboo.com/pictures-t7460.html 
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Environmental factors Hypothesized Not important 
Pathology 
Fibroblast alterations Present Present 
Endothelial alterations Present Present 
Smooth muscle alterations Present Present 
 
Cytokines and chemokines (receptors) in scleroderma 
Cytokines are a large family of glycoproteins that regulates fundamental biological processes, 
which includes immunity, wound healing, haematopoiesis and development of the nervous 
system and they are essential components of adaptive and innate immune systems (Krebs and 
Hilton 2001; Alexander and Hilton 2003). Chemokines are a small family of cytokines that 
participate in immune and inflammatory responses through chemo-attraction and activation of 
leukocytes (Baggiolini 1998). Chemokines function as leukocyte activators and chemo-
attractants in inflammatory responses (Luster 1998). In aetiology of scleroderma, there is 
growing evidence that overproduction of extracellular matrix by activated fibroblasts results 
from the interaction between endothelial cells, macrophages, lymphocytes and fibroblasts 
through mediators such as cytokines, chemokines and growth factors (Yamamoto 2009). 
Suppressor of cytokines signalling 1 (SOCS 1) 
The suppressor of cytokine signalling 1 is a key negative regulator of cytokine signalling and 
immune response (Egan et al. 2003, Hanada et al. 2003, Fenner et al. 2006). The SOCS1 
family of proteins forms part of the negative feedback system that regulates cytokine 
signalling transduction by binding to the cell surface receptors and activating intracellular 
signal transduction such as the JAK-STAT pathway (Krebs and Hilton 2001; Alexander and 
Hilton 2004). The SOCS1 protein target signal transducers for proteosomal destruction 
(Alexander and Hilton 2003) and expression can be induced by a subset of cytokines IL-1, IL-
3, erythropoietin and interferon gamma (Hanada et al. 2003). 
Chemokine ligand 1 (CCL1) and chemokine receptor 8 (CCR8) 
CCL1 is a small glycoprotein secreted by activated T cells belonging to a family of 
chemokines. CCL1 attracts monocytes, NK cells, immature B cells and dendritic cells by 
interacting with a cell surface of chemokine receptors, CCR8 (Millner and Krangel 1992, 
Roos et. al 1997, Hapel and Haque 2002, Haque et al. 2004). CCR8 is a G-protein-coupled 
receptor that is unique for the CCL1 and viral monocyte inflammatory protein-1. It was found 
to be a functional endothelial receptor mediating endothelial chemotaxis in response to CCL1 
and vCCL1 (Dairaghi et al. 1999). 
Other cytokines involved in scleroderma include TGF-β, released by activated 
macrophages or lymphocytes, chemically attracts fibroblasts and increases the synthesis of 
extracellular mass e.g. collagen type I and type III and fibronectin (Yamamoto 2009). TGF-β 
increases levels of TGF-β receptors in fibroblasts leading to increased TGF-β production and 
hence high deposition of extracellular mass and fibrosis (Yamamoto 2009). 
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Connective tissue growth factor (CTGF) is induced in fibroblasts after activation by 
TGF-β (Frazier et al. 1996, Yamamoto 2009). CTGF protein stimulates DNA synthesis and 
up-regulates collagen, fibronectin and integrin expression in fibroblasts (Frazier et al. 1996). 
An existing disproportion between type I and II cytokine responses have been reported 
in the pathogenesis of scleroderma. Interleukin 13 (IL-13) has the capability to suppress pro-
inflammatory cytokines production in monocytes and macrophages and enhance the growth 
and differentiation of B cells and promote immunoglobulin synthesis (Yamamoto 2009). 
Pro-inflammatory chemokines are associated with the initiation of fibrosis and 
sclerosis. This led to the suggestion that chemokines and chemokine receptors may have a 
critical role as mediators of inflammation and fibrosis (Yamamoto 2009). 
 
Autoimmune vitiligo 
Vitiligo is an acquired dermatological disorder characterized by loss of epidermal melanocyte 
leading to de-pigmentation of the skin (Wang and Erf 2004). It is thought that vitiligo is due 
to a combination of several factors which, include genetic susceptibility, immune system and 
environmental components including several kinds of stress (emotional) accumulation of 
toxic melanin precursor in melanocyte (DOPA, dopachrome, 5 6-dihydroxyindole) and 
disturbance of melanocyte homeostasis (impaired intra and extra cellular calcium) (Wick et 
al. 2006 and Kakourou 2009). 
The disease is known to affect up to 2% of the world population (Erf et al. 2001, 
Namazi 2005, Wick et al. 2006 and http://www.aocd.org). Vitiligo is often associated with 
other autoimmune diseases such as hypothyroidism (4-8%), alopecia areata (2-3%) and 5-
15% uveitis often resulting in blindness. People with vitiligo are more prone to develop 
Addison's disease, pernicious anaemia and diabetes mellitus, type I (Erf 2010). 
The disorder usually appears as focal pattern where the disease is limited to one or few 
areas, segmental pattern where de-pigmentation occurs only in one side of the body and as 
generalized pattern which is the most common and occurs symmetrically in both parts of the 
body.  
 
  
Fig. 4. Patients with vitiligo showing loss of pigmentation. Photos 
(http://www.psoriasiscafe.org/vitiligo-pictures.htm)  
 
In both chickens and humans, vitiligo is characterized by spontaneous loss of pigmentation in 
association with uveitis and underlying hair as well as oral mucosa (Lamont et al. 1982 and 
Alkhateeb et al. 2003). There is an increased frequency of association of vitiligo and several 
antibodies suggesting hyperactive immune system in humans and in some patients 
autoantibodies are directed against melanocytes or melanocyte proteins (Lamont et al. 1982 
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Alkhateeb et al. 2003). Evidence of strong association with anti-melanocyte antibodies in 
both animals and humans has been reported (Norrirs et al. 1988). An intrinsic heritable 
melanocyte defect with abnormal and irregular surfaces predisposes the SL chickens to the 
pigment disorder (Boissy et al. 1983).  
The immunopathology of Smyth line vitiligo has been shown to support the 
involvement of cell mediated immune response in destruction of the melanocytes causing 
white feathers in the chickens (Fig. 4) (Wang and Erf 2003; Wang et al. 2004). The 
environmental component in the expression of autoimmune vitiligo was shown by vaccination 
of chickens with a live Turkey herpes virus vaccine (HVT), which triggered the expression of 
SL vitiligo (Erf et al. 2003).  HVT show a strong tropism for epithelium of feather follicles, 
however some studies have revealed that killed HVT had no effect in the expression of 
vitiligo (Erf et al. 2001, 2003). Vaccinations with Newcastle disease virus (NDV) and 
Infectious bronchitis virus (IBV) did not trigger vitiligo suggesting that viral infections and 
antiviral immune activity are not responsible for the expression of autoimmune vitiligo (Erf 
2010).  
 
  
Fig. 5. Phenotypes in SL x BL intercross chickens with vitiligo (Photos. S. Kerje). 
 
Vitiligo in human starts with irregularly shaped melanosomes containing pigmented 
membrane extensions, hyperactive melanization and selective autophagocytosis of 
melanosomes. Both of the aspects of immunity, humoral and cellular, have been implicated to 
have a role in the pathogenesis of vitiligo (Boissy et al. 1984). In the SL chickens, vitiligo 
also starts with the defect in melanocytes followed by an autoimmune response, which 
involves humoral and cellular reactions that eliminate abnormal pigment cells (Rezaei et al. 
2007). The neural theory is associated with segmental vitiligo while the autoimmune 
hypothesis is thought to be associated to generalised vitiligo (Shajil et al. 2006). 
Tissue destruction by the autoimmune cells in humans and animals is associated with 
lack of regulatory function within the immune system, hyperactive immune response and 
altered immune response to endogenous and exogenous factors (Erf 2010). 
It has been shown that the presence of retroviral genes is linked to the expression of vitiligo in 
the SL chicken model and this is because of the structural and sequence similarity to 
exogenous viruses linked to immune dysregulation and their tissue specific expression 
(Sreekumar et al. 2000). 
Increased T cells in the feather pulp of the SL chickens have been noted together with 
the inflammatory leukocytes before and during the onset of vitiligo (Erf 2010). In all (100%) 
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of the SL chickens, antibodies against melanocytes have been detected in serum (Rezaei et al. 
2007). Melanocyte death occurs by apoptosis and is induced by cytotoxic T cells (Erf et al. 
2001 and Wang et al. 2004). In mammalian melanocytes the target antigen for the antibodies 
is the tyrosinase related protein (TRP-1). Anti-pigment cell antibodies, which recognize the 
same melanocyte antigens as in humans have been identified in horses, cats and dogs.  
 
Treatment 
Treatment and re-pigmentation of vitiligo in patients can be achieved with 
immunosuppressive agents such as ultraviolet radiation in combination with Psolaren 
(PUVA), corticosteroids and cytotoxic drugs. 
 
THE CHICKEN GENOME 
 
The chicken genome sequence has enhanced the usefulness of chicken as an animal model 
(Edwards et al. 2005). Analyses have shown that chickens and humans share about 60 percent 
of their genes whereas 88 percent is shared between humans and rodents. This has made 
orthology relationships between chicken and humans more complex and non detectable 
because some proteins and domain families are under-represented in the chicken as compared 
with mammals. The chicken genome, however, provide new insights on evolution, structure 
and gene content of mammalian genomes (International Chicken Genome Sequencing 
Consortium 2004).   
The chicken genome is 1.05 Gbp (International Chicken Genome Sequencing 
Consortium 2004) divided into 39 pairs of chromosomes (nine macrochromosomes and 30 
microchromosomes). Macrochrochromosomes measure from 50-200 Mb in size while 
michrochromosomes have an average of 12 Mb in size (Axelsson et al. 2005) 
Microchromosomes have higher G+C content, more CpG islands as well as high gene density, 
shorter introns, few repetitive sequences and high recombination rates. The female is the 
heterogametic sex carrying Z and W chromosomes while males are homogametic ZZ (Burt 
2007). 
The chicken genome is estimated to have 20 - 23 000 genes 
(http://genome.wellcome.ac.uk) and approximately 30-40% of the mammalian genome in 
size. The difference in size is attributed to reduction of interspersed repeats, segmental 
duplications and pseudogenes of which the chicken has 10% as compared to 50% in humans 
(International Chicken Genome Sequencing Consortium 2004, Burt 2007). Only 44% of the 
conserved sequences represent protein coding genes while conserved non-coding sequences 
are located far from well-defined genes and may have important regulatory functions 
(International Chicken Genome Sequencing Consortium 2004).  
2.8 million SNPs have been reported in the chicken genome database (International 
Chicken Polymorphism Map Consortium 2004; International Chicken Genome Sequencing 
Consortium 2004; Wong et al. 2004). Aligned segments of the chicken and human genomes 
occur in long syntenic blocks with low rates of translocations and more frequent intra-
chromomosomal rearrangement from the last common ancestor (International Chicken 
Genome Sequencing Consortium 2004). 
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MAPPING STRATEGIES 
 
Quantitative Trait Loci (QTL) mapping is described as the application of techniques to 
identify the genes controlling a certain trait. Identification of QTLs is critical for 
understanding the basis of complex traits (Broman 2001). Mapping complex traits has more 
challenges since it is not possible to follow all genomic regions underlying complex traits 
without knowledge of how they segregate (Doerge 2002). Even if statistical associations 
between QTL and markers have been found, genomic regions are sometimes large and 
expensive to undertake and there are also some genetic interactions such as epistasis and non-
genetic factors to take into account (Doerge 2002, Zou 2009). 
According to Broman (2001) experimental populations need to be fixed for relevant 
traits and this is achieved by repeated mating of siblings. A series of crosses is necessary of 
which backcross design is the simplest. Usually, an F2 generation is used and the most 
favourable situation in an F2 design is when all genes underlying the trait of interest are 
diallelic and alternative alleles fixed in both parental lines (Haley and Knott 1994; Perez and 
Varona 2000; Andesson 2001). QTL experiments can be designed in a way that enable 
analysis of complex phenotypes be achievable and this requires large sample of individuals 
that represent the whole population and provide a number of observable recombinations 
(Doerge 2001). 
Two approaches have been assumed in QTL mapping studies and they are the 
infinitesimal, which assumes that traits are determined by the unlimited number of genes, 
each with a small effect, and the finite model which presumes a restricted or finite number of 
genes with a major effect (Hayes 2008). Two common methodologies for QTL mapping 
include the candidate gene approach (assumes that a gene could harbour a mutation that 
results in genetic or physiological variation of a trait) and linkage mapping which uses 
recombination and DNA markers to construct a linkage map (Hayes 2008).  
 
Linkage mapping 
Linkage mapping is determining the order of genes or markers on a chromosome and the 
relative distance between those genes based on the relative recombination frequencies. 
Genetic maps are essential tools for mapping and dissection of complex quantitative trait loci 
and allow for systematic genome scan for genes affecting all kinds of traits (Miles et al. 
2009). 
Linkage mapping is very essential in the identification of candidate genes that may not 
have been studied in detail as it allows defining of chromosomal regions that harbour the 
genes affecting the phenotype (Wick et al. 2006). Wick et al. (2006) described linkage 
mapping as one way of excluding candidate genes since it discriminates genes not in linkage 
with the trait locus, which is better than by functional studies. Linkage analysis looks for 
regions in the genome with a higher proportion of shared alleles among affected individuals, 
which depicts that there is a disease predisposing allele (Carlson et al. 2004). However, 
linkage has not worked well when trying to identify the genes underlying complex diseases 
(Reich 2006). 
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PRELIMINARY RESULTS 
 
In a previous study (Ek et al. unpublished), a backcross generated after crossing pure line 
UCD 200 birds with F1 birds from a cross between UCD200 and red jungle fowl was used to 
identify the genes underlying comb necrosis in the UCD 200 line. A whole genome scan 
including 384 SNPs uncovered 4 genomic regions associated with comb necrosis on 
chromosome 2, 12, 14 and 19 (Fig. 6). 
 
 
Fig, 6. QTL regions identified in the backcross generation after matings between F1 and pure line 
UCD 200. Chromosomes 2 and 14 were highly significant whereas 12 and 19 were suggestive. QTLs 
on chromosome 2 and 12 were identified for comb necrosis at 21 days of age while chromosomes 2, 
14 and a suggestive QTL on 19 were identified for comb necrosis at 175 days of age. 
 
In the autoimmune vitiligo animal model a Hidden Markov algorithm was used to estimate 
the QTL genotypes since it was more efficient than gridQTL in handling markers with mixed 
information content (Ek et al. unpublished). The whole pedigree was genotyped with 384 
SNP markers. Genome wide QTL scan of individual QTL effects using Haley-Knott 
regression and Flexible Intercross Analysis (FIA) revealed marker association on 
chromosomes 3, 9 and 21 with the vitiligo phenotype (Fig. 7). 
 
Figure 7. QTL regions implicated in autoimmune vitiligo in the SL chicken. Chromosome 3 was highly 
significant (P < 0.0001) in both Haley-Knott regression and FIA whilst chromosome 9 was significant 
 14 
in FIA and suggestive using Haley-Knott regression and chromosome 21 was suggestive (P < 0.2) in 
FIA.  
 
The purpose of this project is to  
 
• Confirm the QTLs for autoimmune vitiligo in the F3, F4 and F5 intercross generations 
in a cross between SL and BL. 
• Validate QTL association with comb necrosis in the 2nd backcross generation in a 
pedigree based on a cross between UCD 200 and red jungle fowl. 
• Identify SNPs in the candidate genes, SOCS1, CCR8 and CCL1 underlying the already 
identified QTLs for comb necrosis on chromosome 2, 12, 14 and 19 through 
sequencing of the UCD 200 and red jungle fowl parents from the cross. 
 
MATERIALS AND METHODS 
 
Animals 
UCD 200 pedigree 
Eight red jungle fowls (four males and four females) and eight UCD 200 individuals (four 
males and four females) were mated to produce an F1 generation. 12 UCD 200 (four males 
and eight females) were crossed with F1 generation birds to generate a large backcross 
pedigree of 598 individuals. BC1 males were bred to UCD 200 females to produce 38 BC2 
individuals hatched in three batches.  
 
Smyth line pedigree 
14 Smyth line (SL) and 12 Brown line (BL) parental chickens were crossed to produce 57 F1 
individuals. F1 were intercrossed to generate 496 F2 individuals hatched in seven batches. F2 
was subsequently intercrossed to produce 45 F3 individuals which were intercrossed to 
produce 102 F4 individuals hatched in three batches and F4 were further intercrossed to 
generate 90 F5 individuals hatched in three batches. 
 
Phenotyping 
All individuals in the BC2 generation were visually observed and scored as affected, 
indicating disease, or non-affected for comb necrosis at adult age (more than 175 days of 
age). Individuals with comb necrosis have red, swollen and inflamed combs with part of the 
comb missing. Individuals scored as non-affected has no inflammation and a normally formed 
comb (Fig. 1). 
The vitiligo phenotype were recorded as binary traits, affected or non-affected. 
Affected individuals have lost pigmentation resulting in whole or partly white feathers. Non-
affected individuals have a fully pigmented plumage. All individuals in the F3 to F5 
generations were visually observed and scored according to the above mentioned criteria (Fig. 
5). 
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Blood sampling and DNA extraction 
A total of about 2 ml blood was collected from the brachial vein for serum, plasma and whole 
blood with 5.5% EDTA solution as anticoagulant. Samples were collected from 19 
individuals from the 2nd backcross (F1 x UCD 200) chickens at adult age and from 90 
individuals from F5 intercross generation from the SL x BL cross at 9 weeks of age.  
DNA was extracted by the salt precipitation method using ethanol described by Miller 
et al. (1988) and dissolved in 100 µl 1 x TE solution (10 mM Tris pH 8.0, 0.1 mM EDTA). 10 
µl of blood was used for DNA extraction as all blood cells are nucleated in birds. The amount 
and quality of DNA was measured using the Nanodrop ND 1000 Spectrophotometer (Saveen 
Werner AB, Malmö, Sweden) and the DNA was diluted to a concentration of 50 ng/µl. 
 
Sequencing for detection SNPs in potential candidate genes 
Primers were designed to amplify all exons and introns of the CCR8, CCL1 and SOCS1 
candidate genes. Reference sequences were retrieved from the UCSC genome browser and 
the chicken reference genome sequence WUGSC 2.1/galGal3, 2006 (http://genome.ucsc.edu)   
Gene Fisher software (Giegerich et al. 1996) version 2.0 was used for primer design. 
The sizes of the fragments amplified in the PCR are 781 bp for SOCS1, 1827 bp for CCL1 
and 3350 bp for CCR8. Internal primers were designed for CCR8 and CCL1 regions as 
sequencing from the ends does not cover the entire fragment. All primers can be found in the 
Appendix (Table 8).  
Amplification of the genes using parental DNA as template was carried out in Applied 
Biosystems 2720 thermal cyclers (Applied Biosystems, Foster City, CA, USA). Hot StarTaq 
polymerase (Qiagen, Hilden, Germany) with a touchdown PCR temperature cycling was used 
to allow optimal amplification. The total volume of the PCR reaction was 10 µl including 1 x 
PCR buffer (Qiagen), 2.5 mM MgCl2, 200 µM of dNTPs, 20 pmol of forward and reverse 
primer, 0.1 units of Hot StarTaq polymerase (Qiagen) and about 50 ng of DNA. The 
thermocylcing was as carried out as follows, initial activation of the polymerase at 94⁰C for 
10 min, 14 cycles of denaturing at 94⁰C for 30 sec, annealing temperature starting at 65°C 
decreasing 1 degree per cycle to 52⁰C for 30 sec, extension at 72⁰C for 30 sec, followed by 
26 cycles of denaturing at 94⁰C for 30 sec, annealing temperature of 52⁰C for 30 sec, 
extension at 72⁰C for 30 sec and a final extension at 72⁰C for 5 min. 
DNA fragments including CCL1 and SOCS1 genes were separated in a 2% agarose gel 
and fragments including CCR8 was separated in 1% agarose gel in 0.5 x TBE and visualised 
under ultraviolet light after EtBr staining. 
The QIAQuick Gel extraction Kit (Qiagen) was used for extraction of DNA fragments 
containing the amplified genes form the agarose gel. Elusion was done with 40 µl of elution 
buffer (Qiagen) for fragments containing CCL1 and SOCS1 and with H2O for fragments 
containing CCR8. Sequencing of the amplified products was done at the Rudbeck laboratories 
in Uppsala. 
CodonCode Aligner software, Version 3.5.6 (CodonCode Corporation, Dedham, MA, 
USA) was used to edit, align and compare the DNA sequences. 
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Genotyping using pyrosequencing 
The DNA fragments used as template for pyrosequecnig were amplified using three primers. 
One primer was designed to anneal a few bp 5’ of the SNP position and the other a bit further 
away containing an added tail to fit with the tail primer carrying the biotin label. The resulting 
amplified fragment contains biotin that is used to fish out the fragment prior to 
pyrosequencing using the PyroMark Q96 machine (Qiagen) (See Appendix Fig. 8)  
The SNPs selected for genotyping were previously identified to be informative in the 
cross and genotyped in all individuals in the pedigree.   
 
PCR for amplification of SNPs genotyped in the UCD x JF BC2 generation 
Amplification of the SNPs that were genotyped was carried out with HotStarTaq polymerase 
protocol (Qiagen). The PCR reaction was carried out in a total volume of 25 µl containing of 
1 x PCR buffer (Qiagen), 2.5 mM MgCl2, 20 pmol dNTPs, 20 pmol of each primer except the 
tailed primer that had a concentration of 2 pmol, 0.1 units of HotStarTaq polymerase (Qiagen) 
and about 50 ng of DNA. The thermocycling was carried out as follows, initial activation of 
the polymerase at 94⁰C for 10 min followed by 14 cycles of denaturing at 94⁰C for 30 sec, 
annealing temperature starting at 65°C decreasing 1 degree per cycle to 52⁰C for 30 sec, 
extension at 72⁰C for 30 sec, followed by 26 cycles of denaturing at 94⁰C for 30 sec, 
annealing temperature of 52⁰C for 30 sec, extension at 72⁰C for 30 sec and a final extension 
at 72⁰C for 5 min. 
  
PCR for amplification of SNPs genotyped in the SL x BL F3-F5 generations 
SNPs were amplified using Ampli-TaqGold polymerase (Applied Biosystems). PCR reaction 
was prepared to 25 µl including the reagents below; 1 x PCR buffer (Applied Biosystems), 
2.5 mM MgCl2, 20 pmol dNTPs, 20 pmol of each primer except the tailed primer that had a 
concentration of 2 pmol, 0.1 units of Ampli-TaqGold polymerase (Applied Biosystems) and 
about 50 ng of DNA. The thermocycling was carried out as follows, initial activation of the 
polymerase at 94⁰C for 4 minutes followed by 14 cycles of denaturing at 94⁰C for 30 sec, 
annealing temperature starting at 65°C decreasing 1 degree per cycle to 52⁰C for 30 sec, 
extension at 72⁰C for 30 sec, followed by 26 cycles of denaturing at 94⁰C for 30 sec, 
annealing temperature of 52⁰C for 30 sec, extension at 72⁰C for 30 sec and a final extension 
at 72⁰C for 5 minutes. 
Primer sequences for all markers genotyped can be found in Appendix Table 9. 
Inheritance check was done manually to verify whether the alleles in the individuals are in 
concordance with their parental alleles.  
 
STATISTICAL ANALYSIS 
 
Single Marker Analysis 
Genotypes of SL x BL intercrosses in the F3-F5 generations were analysed using generalized 
linear model in R software. This study used a binomial trait, that is either affected or 
unaffected, and therefore a binomial distribution was assumed. Generalized linear models are 
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usually used for the analysis of binomial distributions. The ANOVA method is used when 
there are more than two marker genotypes.  
The following model was assumed 
  
y = sex + batch2 + ad + d + e 
 
where ad = additive effects d = dominance and e = interaction  
 
RESULTS 
 
Table 2. Incidence of comb necrosis in the UCD 200 2nd back cross generation. 
Sex No. of affected No. of unaffected Frequency 
of affected 
 21 days 175 days 21 days 175 days  
Males  8  0 100 
Females  5  6 42 
Total  13  6 68 
 
Table 3. Incidence of vitiligo in the SL x BL intercross, F3-F5 generation. 
Sex No. of affected No. of unaffected Frequency of 
affected 
 F3 F4 F5 F3 F4 F5  
Males 10  13 7 15 31 38  
Females 6 6 3 13 37 38  
Total 16 19 10 28 68 76  
 36 22 13 64 78 87  
 
SNP identification in candidate genes for systemic sclerosis 
Comparison of sequences from JF 848, JF875, SOCS1 and CCL1 did not show any presence 
of SNPs. We could only obtain a partial sequence from CCR8.  
 
Pyrosequencing 
Genotype data were obtained for all seven markers genotyped. Only two individuals failed to 
give genotypes for marker RS13673471 for Chromosome 2. See Appendix Fig. 10, 11 and 12. 
 
QTL confirmation in the SLxBL F3-5 generations 
The analysis gave suggestive evidence (P=0.1) for association between the marker located on 
chromosome 3, Table 4. No evidence of association was detected for markers on chromosome 
9 and 21 (Table 5 and 6). 
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Table 4. Analysis of variance for chromosome 3.  
Coefficients     
 Estimate std. Error  z value Pr(>|z|) 
Intercept -1.5254 0.4690 3.252 0.00114 ** 
sexM 0.3860 0.4156 0.929 0.35307 
batch21 0.7285 0.4205 1.733 0.08318 
ad 0.6163 0.3656 1.686 0.09187 
dom 0.2071 0.5994 -0.346 0.72969 
---     
Signif. codes 0 '***' 0.001 '**' 0.01 '* 0.1 ' ' 1 
* Z-values are used to compare samples to standard normal distributions (with μ = 0 σ = 1). Error is 
deviation from normal values.  
 
Table 5. Analysis of variance for chromosome 9.  
Coefficients     
 Estimate std. Error  z value Pr(>|z|) 
Intercept -1.0431 0.7341 -1.421 0.1553 
sexM 0.3939 0.4120 0.956 0.3390 
batch21 0.7433 0.4164 1.785 0.0743 
ad 0.2215 0.4930 0.449 0.6532 
dom -0.9583 1,3060 -0.734 0.4631 
---     
Signif. codes 0 '***' 0.001 '**' 0.01 '* 0.1 ' ' 1 
* Z-values are used to compare samples to standard normal distributions (with μ = 0 σ = 1). Error is 
deviation from normal values. 
 
Table 6. Analysis of variance for chromosome 21.  
Coefficients     
 Estimate std. Error  z value Pr(>|z|) 
Intercept -1.0463 1.7525 -0.597 0.5505 
sexM 0.4076 0.4095 0.995 0.3196 
batch21 0.7250 0.4129 1.756 0.0791 
ad -0.5736 0.9077 -0.632 0.5274 
dom -0.9086 3.3648 -0.270 0.7871 
---     
Signif. codes 0 '***' 0.001 '**' 0.01 '* 0.1 ' ' 1 
* Z-values are used to compare samples to standard normal distributions (with μ = 0 σ = 1). Error is 
deviation from normal values. 
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DISCUSSION 
 
A backcross pedigree structure (BC) was created by crossing the F1 males from JF x UCD 
200 cross to UCD 200 to increase the incidence of the disease from 4% observed in the F2 to 
50% in a backcross pedigree structure. Expression of comb necrosis indicating systemic 
sclerosis is alleged to be non-specific to any sex (Gershwin et al. 1981). This study shows that 
100% of males in the 2nd backcross generation showed comb necrosis at day 200 while 
females showed an incidence of 42% making an overall liability of the 2nd backcross 
individuals to 68%. This frequency is higher in comparison to the frequency reported by Ek et 
al. (unpublished) where 95% of the males and 27% of the females in the first backcross (BC) 
generation were found to have comb necrosis and a study by Gershwin et al. (1981) who 
reported 95% of comb necrosis in all chickens. One possible explanation for this is that the 
BC2 generation used in the study was small and perhaps not representative and phenotyping 
of the chickens may have been carried out at different ages. Another possible reason could be 
that the BC2 chickens are old and the ones that are still alive are less sick. This may also 
explain the difference in frequency between the sexes, possibly females are more sensitive or 
maybe there are about unequal number of males and females still alive. 
SSc in chickens can also appear in several forms ranging from limited skin 
involvement to severe or diffuse cutaneous (LeRoy et al. 1988). In most cases, fibrosis and 
thickening of the skin is observed while in some cases involvement can be confined to the 
digits (Fritzler and Kinsella, 1980) (Fig. 2). Mortality in the UCD 200 is 20% at one month, 
40% at four months and 55% at five months of age (Gershwin et al. 1981). We observed 
slightly equivalent mortality rates (49%) at six months (200 days) in our BC2 individuals. 
Most of these animals died at less than one week of age precisely 1-3 days post hatch. The 
precise causes of these deaths are unknown since we did not carry out autopsy. 
Sequencing of the CCR8 gene only provided partial sequence (from both UCD 200 
and JF). This may be explained by the possibility that the DNA from the red jungle fowl 
parentals might be degraded and the gene is relatively large, 3350 bp, and therefore it is 
difficult to amplify a fragment of that length. One possibility could be that there may be some 
SNPs in the primer site that may cause inefficient annealing as low amount of the fragment 
could be amplified. Five SNPs can be found in the CCR8 gene in the draft chicken sequence. 
They are positioned at 2:42719138, 2:42719308, 2:42719563, 2:42719645, 2:42720032 and 
the ones at positions 2:42719308 and 2:42719563 bp are synonymous A/G (rs15966955) and 
C/G (rs13671498) while non-synonymous SNPs were at positions 2:42719645, G/A 
(rs14171803) and 2:42720032 C/T (rs15966952) and a deletion G/- at position 2:42719138 
(rs15090893).   
Comparing these SNPs: in a G/- deletion there is G/G in RJF genotype, for SNP C/T 
RJF has C/C genotype, for SNP C/G RJF has genotypes G/G while layers have A/A, in a C/G 
SNP broilers have genotypes G/G, RJF has C/C and the Silkie has G/G. For A/G SNP RJF 
has genotypes A/A while the Silkie has G/G. (See appendix, Fig. 8 for comparative details). 
In the synonymous variations, amino acids remain at leucine for C/T switch and histidine for 
G/A transition while in non-synonymous variations the amino acids in C/G switch change 
from glycine to alanine whilst in A/G shift leucine is changed to proline. The roles that these 
SNPs may have in the candidate genes are shown in Appendix Fig. 9. 
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In the autoimmune vitiligo model, we noted frequencies of 16% in males and 7% in 
females of the F5 generation. This is lower than expected because previous analysis showed a 
prevalence of 40% in the F2 generation. Nonetheless, we are still expecting more chickens to 
show the disease as they grow older. It is known that the disease is more prevalent in the 
adolescence stage up to early adulthood (Erf 2010). We realized a reduction, in incidences of 
the disease from generation F3 to F5 at 21 weeks of age however, this should be verified as 
the chickens grow. 
F5 generation may not have been at the right time and more individuals may get the 
disease at a later stage. 
We used one marker per QTL region in the statistical analysis. Since the analysis 
program used required a haplotype, i.e two markers, the genotyping marker was duplicated in 
the analysis. We did not observe any significant association in any of the 3 chromosomes 
analysed, only a suggestive association was found between the phenotype and the marker on 
chromosome 3. These results were not surprising because in the previous generation 
analyzed, the QTL on chromosome 3 was significant in both Haley-Knott and FIA (P < 
0.0001) whereas the QTL on chromosome 9 was only significant in FIA (P < 0.05) and the 
one on chromosome 21 was suggestive (P < 0.2) (See Fig. 6). (Ek et al. unpublished). 
Simulations and analyses of experimental data showed that the power of FIA was equal or 
better than Haley-Knott regression and insensitive to allele fixation in the founders. This 
method provides good estimates of QTL as well (Rönnegård et al. 2008). 
Genotyping families with additional markers may increase the information content 
hence improving the likelihood of detecting true susceptibility loci. Results from simulation 
studies suggested that breeding populations in QTL mapping should be more or equal to 100 
individuals (Darvasi and Soller 1995). Our study populations for F3 and F4 are lower than the 
suggested size except for F5, and this may lower the power of mapping. Rönnegård et al. 
(2008) showed that using few parental lines to generate a large F2 population increases the 
power of QTL detection while using a large parental population increase the chance of having 
more alleles with different effects if they are not fixed. 
 
FUTURE PROSPECTS 
 
A large population of UCD x JF BC2 individuals should be created to enable and increase the 
power of the analysis.  
In the SLxBL F5 generation several more markers should be genotyped under the 
QTLs and males recombinant for different regions should be selected and crossed with pure 
line SL females to generate a back-cross to narrow down the QTL region. Darvasi and Soller 
(1995) showed that advanced intercross lines provide a three-five fold reduction in the 
confidence interval of QTL map location after eight generations i.e. in F10 as compared to an 
F2 or a backcross.  
When additional potential candidate genes have been identified, their functions can be 
studied using the tissues that have been collected and are currently stored in freezers. 
Expression analysis could be carried out after extraction of RNA from the collected tissues 
(See list of collected tissues in Appendix Table 7).  
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CONCLUSION 
 
Generally, causes of autoimmune diseases are unknown and the search for ultimate causes 
requires animal models. Such animal models are important in understanding the progression 
of diseases in humans since it is possible to set up specific crosses in animals which is not 
possible in humans. Several animal models have been proposed based on whether the disease 
is induced or inherited. Completion of the chicken genome sequence has enhanced the 
chicken as an animal model for understanding human diseases. Despite these advantages, 
animal models are however not absolute solutions to elucidating human diseases as animals 
and humans have physiological differences as different species and have different protein 
functions. Furthermore, there are differences in the immune systems between mammals and 
birds since birds have the bursa.  In mammals tolerance is induced in the thymus (for T cells) 
and bone marrow (for B cells) while in birds maturance and tolerance are induced in the bursa 
However, identified genes may give a hint to the pathways of their involvement in disease 
progression.   
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APPENDIX 
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Fig. 8 pyrosequencing assay for genotyping of SSc and vitiligo individuals.  
 
 
 
 
Fig. 9 Comparison of the CCR8 SNPs in different chicken strains 
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Fig,10. SNP variations in the CCR8 and proteins families coded for.  
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Fig.11 Pyrogram of a homozygous GG SNP genotype   
 
 
Fig.12 Pyrogram of a heterozygous AG SNP genotype   
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Fig.12 Pyrogram of a homozygous AA SNP genotype   
 
 
Fig.13 Expected or theoretical genotype of the AA individual 
 
 
Fig.14 Expected or theoretical genotype of the heterozygous AG individual 
 26 
 
 
Fig.15 Expected or theoretical genotype of the homozygous GG individual. 
 
Table 7. Tissue samples collected form SSc and vitiligo chickens at slaughter. 
Disorder 
Tissue SSc Vitiligo 
Subcutaneous fat √ √ 
Spleen √ √ 
Testis √ √ 
Breast muscle √ √ 
Liver √ √ 
Ovary √ √ 
Heart muscle(apex) √ √ 
Skin √ √ 
Comb √ X 
Feather √ √ 
Thyroid √ √ 
Eyes √ X 
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Table 8. Primers used for sequencing of the candidate genes in SSc. 
Gene Primer Primer sequence 
CCR8 CCR8_rev  TACCCATGACTCTTACCTCGTA 
 CCR8_int1443_rev GCATACACAGAGTGCACA 
 CCR8_int2074_rev CAAAAGAGGACTGTGAGGA 
 CCR8_fwd ATAACATCTGCTACGGAGAGGA 
 CCR8_int2020_fwd CACAGTGCCTTCAACAGA 
CCL1 CCL1_fwd GTGGTTTGTCGGTGGCAGCA 
 CCL1_int1066_rev CTGCTGGAAGATTGGGAA 
 CCL1_int995_fwd CACAGTACGCCTCTCTCA 
 CCL1_rev TGCATTGACCCTGCATTGAATCCA 
SOCS1 SOCS1_fwd CCGTAGCCACTGACGCTATGGA 
 SOCS1_rev TAAAAACCCAGGAAGCTGGA 
 
 
Table 9. Primers used in genotyping of SNPs through pyrosequencing  
Chrom. Forwad primer Reverse primer 
 
3 CACGACGTTGTAAAACGACAACTTG
CATCAA TGCCAGTGA 
ATGAGTCTCTCTTGTCRATCA
CACA 
9 CACGACGTTGTAAAACGACTTAGCA
GCA TTGTTCTAGTTCCG 
CAA 
AAAACCCCACATCTAGTTTC 
21 CACGACGTTGTAAAACGACAGGCTG 
GGAGTTGGTGCACAG  
GGGCTCAGGAAGCACGCAC 
2 CACGACGTTGTAAAACGACCACTGA
GTTTGT TGAATATGGCT 
CATGTCACTATAACTTCACCT
GC 
12 CACGACGTTGTAAAACGACTGCTGT
GACTGG GTTGGAGG 
CGCTGCCTGAGCAGAGCTGT 
14 AACAGCAAGAGTAATATAAGAT CACGACGTTGTAAAACGACTG
ACTT AACACCCCATTTCTCTA 
19 TCACACATGCAAACCAGACAC CACGACGTTGTAAAACGACG
GT ACAGCGCACATGGAAAAG 
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SNPs in QTL used in pyrosequencing 
 
Chromosome 2 marker RS13673471 
CAGATGCTAGTCAGGCTCACTGAGTTTGTTGAATATGGCTTGCATACAGTGATGG
TTACTTAAACACCTGCTCCTCCATTGCTTCCTGTGAATATTCAGT[C/T]GCAGGTGA
AGTTATAGTGACATGCCAGGAGAAGGTAGCAGCTTAAACCAGTACAGTGTTTCA
ACATTTATTGATTTATAAGAAATCACAGAAGTGCACAT 
 
Chromosome 12 marker RS14975805 
GAAATGCTGTGACTGGGTTGGAGGCTCCCAGCAGCAGGCAGGAGGTCTGACACA
GCGGGGATGAACAAACTTCCGCTGGTACAAAAGGGATGACAGAACA[T/C]ACAG
CTCTGCTCAGGCAGCGGTGCCCATCAGAACCCCCTTGGGTyCATCCAGGCCCTTA
GCAAAGCCACTCGGCAGCCCTGAGCCyGGCGCACGGCCCCA 
 
Chromosome 14 marker RBL1140 
TGAAGGGTTCAAGAGTTAACAGTCAAAAATTGGCAGTGATCATTTTAATTTTTGA
TTTCTGACCAGCAGTATGCTGCAACAGCAAGAGTAATATAAGATC[A/G]TTGCTA
GGCAAATCGTGGCCCAAAAGAGCAGAGAAGGTAGAGAAATGGGGTGTTAAGTCA
CAGAGAACGATAACATCCAGGGCATACTCTGAAGAAGGTG 
 
Chromosome 19 marker RS14123499 
TGTGCCGTGACCTTAGCAAAAAGTGGTCGTCTCGGGAGCGCATGGAAATTCTCCC
ATTCTAATCAAGAGGAATTAAACTTCACACATGCAAACCAGACAC[G/A]CCTCTT
CTGAAAACCTCAGTGCTAACAACGTGCGGTACATTAACTTGATTAATCCTAACGT
AATCTTTTCCATGTGCGCTGTACCGATGCCTTCTCCACC 
 
R script 
phen=as.matrix(read.table("phen.out")) 
 batch=as.matrix(read.table("batch_sex.out")) 
 
prob=as.matrix(read.table("KH_chr21.out",skip=2)) 
 
prob=subset(prob,phen[,2]!='-999') 
batch=subset(batch,phen[,2]!='-999') 
phen=subset(phen,phen[,2]!='-999') 
 
 prob=prob[594:738,] 
 batch=batch[594:738,] 
 phen=phen[594:738,] 
 
y=as.numeric(phen[,2]) 
sex=as.factor(batch[,2]) 
batch=as.matrix(batch[,3:6]) 
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write(t(batch),ncol=4,file='temp_batch.txt') 
batch=as.matrix(read.table("temp_batch.txt")) 
ad=prob[,2]-prob[,3] 
dom=prob[,4]+prob[,5] 
 
lm1=lm(y~sex+batch+ad+dom) 
 
glm1=glm(y~sex+batch+ad+dom,family=binomial) 
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